Gilead Sciences, Inc.
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Common stock repurchases — Cash paid by Year
Common stock repurchases — Cash paid ($M) ($M)
Gilead Sciences Common stock repurchases — Cash paid: $1,922M in FY2025, up 67.1% from a year earlier.
Latest, FY2025
1,922
Period ended Dec 31, 2025
Change on a year earlier
+67.1%
1,150 in FY2024
History
12 years
Since FY2014
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Cash Flows.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Common stock repurchases — Cash paid ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,922 | +67.1% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 1,150 | +15.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 1,000 | -28.4% | Form 10-K (filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 1,396 | +155.7% | Form 10-K (filed 2025-02-28) ↗ |
| FY2021 | Dec 31, 2021 | 546 | -65.5% | Form 10-K (filed 2024-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 1,583 | -9.5% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 1,749 | -39.7% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 2,900 | +204.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 954 | -91.3% | Form 10-K (filed 2019-02-26) ↗ |
| FY2016 | Dec 31, 2016 | 11,001 | +10.0% | Form 10-K (filed 2019-02-26) ↗ |
| FY2015 | Dec 31, 2015 | 10,002 | +87.0% | Form 10-K (filed 2018-02-27) ↗ |
| FY2014 | Dec 31, 2014 | 5,349 | – | Form 10-K (filed 2017-02-27) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Common stock repurchases — Cash paid ($M), annual FY2014–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/cap-buyback-cash
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.